Senior Director, HR Business Partner

Vera Therapeutics (Nasdaq: VERA) is a late clinical-stage biotechnology company focused on developing treatments for serious immunological diseases. Vera’s mission is to advance treatments that target the source of immunologic diseases to change the standard of care for patients. Vera’s lead product candidate is atacicept, a fusion protein self-administered at home as a subcutaneous once-weekly injection that blocks both B-cell Activating Factor (BAFF) and APRIL, which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including IgA nephropathy. Vera is also evaluating atacicept in other immunologic disorders. Additionally, Vera is developing VT-109 (a novel, next-generation dual BAFF/APRIL inhibitor in preclinical development) and MAU868 (a monoclonal antibody designed to neutralize BK virus). For more information, please visit:

Our values are the cornerstone of our culture. Our values guide everything we do—from how we hire great peop...

Ready to Apply?

Submit your application today and join our talented team at Vera Therapeutics, Inc..